Animal vaccines are biological preparations used to improve the immunity of animals. Animal vaccines are generally prepared from weakened or dead microbes that can cause a particular disease when in their healthy state. Some of the animal vaccines are also formulated using a part of a microbe's body such as protein subunits or toxic components.
These components act as stimulating agents that trigger the immune system in an animal body. This then prepares the necessary antibodies to act against the microbes present in the body or to destroy any that it encounters in the future. Based on their applications, animal vaccines are predominantly categorized into livestock vaccines, companion vaccines, and aquaculture vaccines.
The analysts forecast the Global Animal Vaccines market to grow at a CAGR of 8.25 percent over the period 2013-2018.
This report covers the present scenario and the growth prospects of the Global Animal Vaccines market for the period 2014-2018. To calculate the market size, the report considers the revenue generated from the sales of various animal vaccines. In terms of vaccines types, the Global Animal Vaccines market can be segmented into six: Companion Animal Vaccines, Livestock Vaccines, Porcine Vaccines, Poultry Vaccines, Equine Vaccines, and Other Animal Vaccines.
The report, the Global Animal Vaccines Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the APAC and EMEA regions; it also covers the Global Animal Vaccines market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.
One of the major emerging trends in this market is an increase in acquisitions. Vendors have been focusing on acquisitions to increase their foothold in the market through increased investments.
According to the report, one of the main drivers of this market is an increase in the prevalence of animal diseases worldwide, in both developed and developing countries. As a result, the use of animal vaccines has increased. The increasing susceptibility of animals to chronic diseases has driven the revenue growth of this market to a great extent.
Further, the report states that one of the main challenges that the market faces is a rise in the maintenance costs of vaccines. Though the animal vaccines have numerous benefits, the high cost of these vaccines hinders acceptability among end-users.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Key Topics Covered:
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
04. Market Research Methodology
06. Market Landscape
07. Market Segmentation by Products
08. Market Segmentation by Technology
09. Geographical Segmentation
10. Buying Criteria
11. Market Growth Drivers
12. Drivers and their Impact
13. Market Challenges
14. Impact of Drivers and Challenges
15. Market Trends
16. Trends and their Impact
17. Vendor Landscape
- Bayer HealthCare
- Elanco Animal Health
- Merck Animal Health
- Novartis Animal Health
- Biogenesis Bago
- Boehringer Ingelheim
- Ceva Santé Animale
- Indian Immunologicals
- Lohmann Animal Health International
For more information visit http://www.researchandmarkets.com/research/jq2qvt/global_anima
Media Contact: Laura Wood, +353-1-481-1716, firstname.lastname@example.org
SOURCE Research and Markets